Lipid and apolipoprotein levels and distribution in patients with hypertriglyceridemia: effect of triglyceride reductions with atorvastatin.

Le, N A; Innis-Whitehouse, W; Li, X; Bakker-Arkema, R; Black, D; Brown, W V

Le, N A; Innis-Whitehouse, W; Li, X; Bakker-Arkema, R; Black, D; Brown, W V.

Affiliation

Le NA; Department of Medicine, Emory University, Atlanta, GA, USA. ale@emory.edu

Metabolism ; 49(2): 167-77, 2000 Feb.

Article in En | MEDLINE | ID: mdl-10690940

Subject(s)

Anticholesteremic Agents/therapeutic use; Apolipoproteins/blood; Glycoproteins; Heptanoic Acids/therapeutic use; Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use; Hypertriglyceridemia/blood; Hypertriglyceridemia/drug therapy; Lipids/blood; Pyrroles/therapeutic use; Apolipoproteins B/blood; Apolipoproteins E/blood; Atorvastatin; Carrier Proteins/blood; Cholesterol Ester Transfer Proteins; Cholesterol, VLDL/blood; Chromatography, High Pressure Liquid; Double-Blind Method; Electrophoresis, Polyacrylamide Gel; Enzyme-Linked Immunosorbent Assay; Humans; Lipoproteins, HDL/blood; Particle Size; Triglycerides/blood

Search on Google

Add to My VHL

XML

PubMed Links

Database: MEDLINE Main subject: Apolipoproteins / Pyrroles / Glycoproteins / Hypertriglyceridemia / Hydroxymethylglutaryl-CoA Reductase Inhibitors / Heptanoic Acids / Lipids / Anticholesteremic Agents Type of study: Clinical_trials Language: En Journal: Metabolism Year: 2000 Type: Article Affiliation country: United States

Search on Google

Add to My VHL

XML

PubMed Links